Alpha 2.0
Login Register
» Authors » Aleksandra Chabior

Aleksandra Chabior

Explore the profile of Aleksandra Chabior including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 13
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Biomedical Engineering
Top 10 Co-Authors
Aleksandra Gasecka
Grzegorz Opolski
Michal Marchel
Agata Tyminska
Roksana Gozdowska
Marcin Grabowski
Krzysztof Ozieranski
Agnieszka Makowska
Jakub Michal Zimodro
Magdalena Durlik
Published In
Kardiol Pol
Ann Agric Environ Med
Porto Biomed J
Pol Arch Intern Med
Cardiol Rev
Affiliations
Soon will be listed here.
Recent Articles
1.
Advances in myocarditis management in the light of the latest research and recent guidelines of the European Society of Cardiology
Chabior A, Tyminska A, Pawlak A, Giordani A, Caforio A, Grabowski M, et al.
Cardiol J . 2024 Jan; 31(2):342-351. PMID: 38247433
Myocarditis remains an unknown disease with varying clinical manifestations, often leading to heart failure. The latest 2021 and 2022 guidelines of the European Society of Cardiology (ESC) are the first...
2.
ST-segment elevation myocardial infarction and sudden cardiac arrest due to vasospastic angina: An underappreciated challenge
Zimodro J, Mucha M, Chabior A, Gasecka A, Koltowski L
Kardiol Pol . 2023 Sep; 81(11):1160-1162. PMID: 37718583
No abstract available.
3.
Sex differences in incidence, management, and outcomes in adult patients aged over 20 years with clinically diagnosed myocarditis in the last 10 years: data from the MYO‑PL nationwide database
Ozieranski K, Tyminska A, Chabior A, Kruk M, Kon B, Maciejewski C, et al.
Pol Arch Intern Med . 2022 Jan; 132(4). PMID: 35084153
Introduction: Comprehensive epidemiological data about the course of myocarditis and sex differ-ences are lacking. Objectives: We aimed to investigate the current differences in the incidence, clinical characteristics, management, and outcomes...
4.
Expression of versican mRNA transcript to predict cardiac remodelling after myocardial infarction
Chabior A, Gasecka A, Marchel M, Gozdowska R, Makowska A, Maciak K, et al.
Kardiol Pol . 2021 Jun; 79(7-8):833-840. PMID: 34166520
Background: Adverse left-ventricular remodelling (LVR) is defined as an increase in end-diastolic left-ventricular volume by 20% 6 months after acute myocardial infarction (AMI). LVR is associated with cardiac dysfunction, therefore...
5.
Circulating microRNA in Heart Failure-Practical Guidebook to Clinical Application
Gozdowska R, Makowska A, Gasecka A, Chabior A, Marchel M
Cardiol Rev . 2020 Sep; 30(1):16-23. PMID: 32897886
Heart failure (HF) remains a major cause of death and disability worldwide. Currently, B-type natriuretic peptide and N-terminal probrain natriuretic peptide are diagnostic biomarkers used in HF. Although very sensitive,...
6.
Comparison of metabolic syndrome rates in living-donor and deceased-donor kidney recipients - A three-year follow-up:
Chabior A, Gozdowska J, Jedrych E, Durlik M
Porto Biomed J . 2020 Apr; 2(5):177. PMID: 32258620
No abstract available.
7.
The role of acetylsalicylic acid and circulating microRNAs in primary prevention of cardiovascular events in patients with Diabetes Mellitus Type 2 - A Review
Chabior A, Pordzik J, Mirowska-Guzel D, Postula M
Ann Agric Environ Med . 2019 Dec; 26(4):512-522. PMID: 31885222
Introduction: Type 2 diabetes mellitus (T2DM) is a common metabolic disorder, which carries a risk for atherosclerosis and cardiovascular impairment. The purpose of this review is to demonstrate the role...